Diabetes-Related Cognitive Decline, a Global Health Issue, and New Treatments Approaches.

Vera Novak, Federico Gomez, Alexandre Campos Dias, Daniela A Pimentel, Freddy J Alfaro
Author Information
  1. Vera Novak: Beth Israel Deaconess Medical Center, Boston, MA, USA.
  2. Federico Gomez: Beth Israel Deaconess Medical Center, Boston, MA, USA.
  3. Alexandre Campos Dias: Beth Israel Deaconess Medical Center, Boston, MA, USA.
  4. Daniela A Pimentel: University of Massachusetts Medical School, Worchester, MA, USA.
  5. Freddy J Alfaro: Beth Israel Deaconess Medical Center, Boston, MA, USA.

Abstract

The epidemic of type 2 diabetes (T2DM) is spreading around the globe and challenging the unprecedented success of health sciences in increasing longevity. T2DM has been linked to accelerated brain aging, functional decline in older adults and dementia. Brain insulin resistance and glycemic variability are potential mechanisms underlying T2DM-related brain damage and Cognitive Decline. Intranasal insulin therapy has emerged as a potential new treatment for T2DM-related cognitive impairment. Wearable technologies now allow better monitoring of behaviors and glycemic levels over several days and deliver real time feedback that can be used to improve self-management and lead to new prevention strategies and therapies for T2DM complications.

Keywords

References

  1. Am J Epidemiol. 2008 Nov 15;168(10):1132-9 [PMID: 18836152]
  2. Artif Intell Med. 2008 Feb;42(2):153-63 [PMID: 18234481]
  3. Neuroendocrinology. 2007;86(2):136-42 [PMID: 17643054]
  4. J Telemed Telecare. 2017 Feb;23(2):263-272 [PMID: 26880695]
  5. BMC Public Health. 2015 May 27;15:509 [PMID: 26012783]
  6. Diabet Med. 2015 May;32(5):609-17 [PMID: 25661981]
  7. Neurology. 2004 Oct 12;63(7):1181-6 [PMID: 15477535]
  8. Diabetes Care. 2011 Oct;34(10):2152-7 [PMID: 21836103]
  9. Hum Brain Mapp. 2014 May;35(5):1944-56 [PMID: 23907764]
  10. Drugs. 2012 Jan 1;72(1):49-66 [PMID: 22191795]
  11. N Engl J Med. 2007 Jul 26;357(4):370-9 [PMID: 17652652]
  12. Diabetes. 2014 Nov;63(11):3596-605 [PMID: 24947353]
  13. Int J Clin Exp Pathol. 2014 Dec 01;7(12):8848-54 [PMID: 25674254]
  14. Circ J. 2011;75(5):1042-8 [PMID: 21441696]
  15. Diabetes Metab Res Rev. 2006 Nov-Dec;22(6):423-36 [PMID: 16506274]
  16. Diabetes Care. 2014;37(3):751-9 [PMID: 24101698]
  17. BMC Womens Health. 2015 Mar 27;15:30 [PMID: 25886945]
  18. N Engl J Med. 2008 Jun 12;358(24):2630-3 [PMID: 18539918]
  19. J Clin Endocrinol Metab. 2012 Feb;97(2):366-76 [PMID: 22162476]
  20. Nat Neurosci. 2002 Jun;5(6):514-6 [PMID: 11992114]
  21. Neurology. 2015 Aug 4;85(5):450-8 [PMID: 26156513]
  22. J Clin Invest. 2006 Jul;116(7):1761-6 [PMID: 16823473]
  23. Diabetologia. 2010 Jan;53(1):58-65 [PMID: 19882137]
  24. Diabetes Care. 2009 Feb;32(2):221-6 [PMID: 19171735]
  25. Diabetologia. 2008 Jul;51(7):1321-6 [PMID: 18488188]
  26. CNS Drugs. 2013 Jul;27(7):505-14 [PMID: 23719722]
  27. Dement Geriatr Cogn Disord. 2010;30(5):381-6 [PMID: 20962529]
  28. Stud Health Technol Inform. 2004;108:49-55 [PMID: 15718629]
  29. Neurology. 2008 Feb 5;70(6):440-8 [PMID: 17942819]
  30. Diabetes. 2015 Mar;64(3):1025-34 [PMID: 25249577]
  31. Arch Neurol. 2012 Jan;69(1):29-38 [PMID: 21911655]

Grants

  1. R01 AG028076/NIA NIH HHS
  2. R01 DK103902/NIDDK NIH HHS
  3. R21 DK084463/NIDDK NIH HHS

Word Cloud

Created with Highcharts 10.0.0T2DM2braindeclineinsulinglycemicpotentialT2DM-relatedcognitiveIntranasalnewWearableepidemictypediabetesspreadingaroundglobechallengingunprecedentedsuccesshealthsciencesincreasinglongevitylinkedacceleratedagingfunctionalolderadultsdementiaBrainresistancevariabilitymechanismsunderlyingdamagetherapyemergedtreatmentimpairmenttechnologiesnowallowbettermonitoringbehaviorslevelsseveraldaysdeliverrealtimefeedbackcanusedimproveself-managementleadpreventionstrategiestherapiescomplicationsDiabetes-RelatedCognitiveDeclineGlobalHealthIssueNewTreatmentsApproachesGlycemicVariabilityInsulinTypeDiabetesTechnology

Similar Articles

Cited By (5)